Evidence map›Paper›PMID 32916870›Full record

ArticleNanomaterials (Basel, Switzerland)2020

Sulpho-Salicylic Acid Grafted to Ferrite Nanoparticles for n-Type Organic Semiconductors.

Cristian Ravariu, Dan Mihaiescu, Alina Morosan, Bogdan Stefan Vasile, Bogdan Purcareanu

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Cristian RavariuDepartment of Electronic Devices Circuits & Architectures, Faculty of Electronics Telecommunications and Information Technology, Polytechnic University of Bucharest, S6 060042 Bucharest, Romania.ORCID 0000-0002-1483-2583
Dan MihaiescuDepartment of Organic Chemistry "Costin Nenitescu", Faculty of Applied Chemistry and Materials Science, Politehnica University of Bucharest, S1 011061 Bucharest, Romania.
Alina MorosanDepartment of Organic Chemistry "Costin Nenitescu", Faculty of Applied Chemistry and Materials Science, Politehnica University of Bucharest, S1 011061 Bucharest, Romania.
Bogdan Stefan VasileDepartment of Engineering of Oxide Materials and Nanomaterials, Faculty of Applied Chemistry and Materials Science, Politehnica University of Bucharest, S1 011061 Bucharest, Romania.ORCID 0000-0002-2267-6453
Bogdan PurcareanuS.C. Biotehnos S.A., Gorunului Street 3, 075100 Otopeni, Romania.
Universitatea Națională de Știință și Tehnologie Politehnica București · ROUniversity of Bucharest · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A disadvantage of the use of pentacene and typical organic materials in electronics is that their precursors are toxic for manufacturers and the environment. To the best of our knowledge, this is the first report of an n-type non-toxic semiconductor for organic transistors that uses sulpho-salicylic acid-a stable, electron-donating compound with reduced toxicity-grafted on a ferrite core-shell and a green synthesis method. The micro-physical characterization indicated a good dispersion stability and homogeneity of the obtained nanofilms using the dip-coating technique. The in-situ electrical characterization was based on a point-contact transistor configuration, and the increase in the drain current as the positive gate voltage increased proved the functionality of the n-type semiconductor.

Indexed as

green semiconductorsnanocoren-type filmorganic shell

Identifiers

PMID32916870
PMCPMC7557432
OpenAlexW3084283271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.